The DOI matches its Crossref record; 279 of the 279 references it cites were found in a registry or an index.
microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis
Open accessAbstract
microRNAs (miRNAs) are small non-coding RNA molecules, evolutionary conserved. They target more than one mRNAs, thus influencing multiple molecular pathways, but also mRNAs may bind to a variety of miRNAs, either simultaneously or in a context-dependent manner. miRNAs biogenesis, including miRNA transcription, processing by Drosha and Dicer, transportation, RISC biding, and miRNA decay, are finely controlled in space and time. miRNAs are critical regulators in various biological processes, such as differentiation, proliferation, apoptosis, and development in both health and disease. Their dysregulation is involved in tumor initiation and progression. In tumors, they can act as onco-miRNAs or oncosuppressor-miRNA participating in distinct cellular pathways, and the same miRNA can perform both activities depending on the context. In tumor progression, the angiogenic switch is fundamental. miRNAs derived from tumor cells, endothelial cells, and cells of the surrounding microenvironment regulate tumor angiogenesis, acting as pro-angiomiR or anti-angiomiR. In this review, we described miRNA biogenesis and function, and we update the non-classical aspects of them. The most recent role in the nucleus, as transcriptional gene regulators and the different mechanisms by which they could be dysregulated, in tumor initiation and progression, are treated. In particular, we describe the role of miRNAs in sprouting angiogenesis, vessel co-option, and vasculogenic mimicry. The role of miRNAs in lymphoma angiogenesis is also discussed despite the scarcity of data. The information presented in this review reveals the need to do much more to discover the complete miRNA network regulating angiogenesis, not only using high-throughput computational analysis approaches but also morphological ones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–279 of 279
Human snoRNA-93 is processed into a microRNA-like RNA that promotes breast cancer cell invasion
Patterson, D. G., Roberts, J. T., King, V. M., Houserova, D., Barnhill, E. C., Crucello, A., Polska, C. J., Brantley, L. W., Kaufman, G. C., Nguyen, M., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0032-8 · Cited by 83
Malanga, M., Czubaty, A., Girstun, A., Staroń, K., & Althaus, F. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709495200 · Cited by 82
Stress Induces p38 MAPK-Mediated Phosphorylation and Inhibition of Drosha-Dependent Cell Survival
Yang, Q., Li, W., She, H., Dou, J., Duong, D. M., Du, Y., Yang, S., Seyfried, N. T., Fu, H., Gao, G., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.004 · Cited by 82
MicroRNA-17~92 inhibits colorectal cancer progression by targeting angiogenesis
Ma, H., Pan, J., Jin, L., Wu, J., Ren, Y., Chen, P., Xiao, C., & Han, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.011 · Cited by 82
Schmid, G., Notaro, S., Reimer, D., Abdel-Azim, S. A.-F., Duggan-Peer, M., Holly, J., Fiegl, H., Rössler, J., Wiedemair, A., Concin, N., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2135-2 · Cited by 81
Huang, T.-H., & Chu, T.-Y. (2013) · Oncogene · doi:10.1038/onc.2013.335 · Cited by 80
Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells
Lewis, K. A., Jordan, H. R., & Tollefsbol, T. O. (2018) · Cancers · doi:10.3390/cancers11010023 · Cited by 77
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs
Leone, P., Buonavoglia, A., Fasano, R., Solimando, A. G., Re, V. D., Cicco, S., Vacca, A., & Racanelli, V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122030 · Cited by 76
Ha, T.-Y. (2011) · Immune Network · doi:10.4110/in.2011.11.5.227 · Cited by 74
Mature microRNAs identified in highly purified nuclei from HCT116 colon cancer cells
Park, C. W., Zeng, Y., Zhang, X., Subramanian, S., & Steer, C. J. (2010) · RNA Biology · doi:10.4161/rna.7.5.13215 · Cited by 72
microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review)
Yang (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.970 · Cited by 72
WANG, W., WILFRED, B., BALDWIN, D., ISETT, R., REN, N., STROMBERG, A., & NELSON, P. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.01.005 · Cited by 70
Hong, S., Noh, H., Chen, H., Padia, R. N., Pan, Z. K., Su, S., Jing, Q., Ding, H., & Huang, S. (2013) · Science Signaling · doi:10.1126/scisignal.2003706 · Cited by 70
Freimer, J. W., Hu, T., & Blelloch, R. (2018) · eLife · doi:10.7554/elife.38014 · Cited by 69
Tsuchiya, S., Oku, M., Imanaka, Y., Kunimoto, R., Okuno, Y., Terasawa, K., Sato, F., Tsujimoto, G., & Shimizu, K. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp255 · Cited by 68
Kuo, T.-Y., Hsi, E., Yang, I., Tsai, P., Wang, J., & Juo, S. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031587 · Cited by 67
Enhancement of poly‐adenosine diphosphate‐ribosylation in human hepatocellular carcinoma
Nomura, F., Yaguchi, M., Togawa, A., Miyazaki, M., Isobe, K., Miyake, M., Noda, M., & Nakai, T. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02193.x · Cited by 67
MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma
Zhang, J., Jin, H., Liu, H., Lv, S., Wang, B., Wang, R., Liu, H., Ding, M., Yang, Y., Li, L., et al. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.11 · Cited by 63
Leaderer, D., Hoffman, A. E., Zheng, T., Fu, A., Weidhaas, J. B., Paranjape, T., & Zhu, Y. (2011) · Europe PMC (PubMed Central) · Cited by 60
Pasculli, B., Barbano, R., Fontana, A., Biagini, T., Viesti, M. P. D., Rendina, M., Valori, V. M., Morritti, M. G., Bravaccini, S., Ravaioli, S., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01415 · Cited by 60
Liu, W., Lv, C., Zhang, B., Zhou, Q., & Cao, Z. (2017) · RNA · doi:10.1261/rna.059592.116 · Cited by 59
Erythropoietin in tumor angiogenesis
Annese, T., Tamma, R., Ruggieri, S., & Ribatti, D. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.12.013 · Cited by 59
Self-citationLi, Z.-F., Liang, Y.-M., Lau, P., Shen, W., Wang, D., Cheung, W.-T., Xue, C., Poon, L., & Lam, Y. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070869 · Cited by 58
MiR-29a modulates the angiogenic properties of human endothelial cells
Yang, Z., Wu, L., Zhu, X., Xu, J., Jin, R., Li, G., & Wu, F. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.054 · Cited by 57
Tomasetti, M., Gaetani, S., Monaco, F., Neužil, J., & Santarelli, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01293 · Cited by 57
Rosano, S., Corà, D., Parab, S., Zaffuto, S., Isella, C., Porporato, R., Hoza, R. M., Calogero, R., Riganti, C., Bussolino, F., et al. (2020) · eLife · doi:10.7554/elife.48095 · Cited by 57
MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
Yq, W., Jiao, X.-L., Zhang, S.-Y., Xu, Y., Li, S., & Bh, K. (2019) · PubMed · doi:10.26355/eurrev_201909_18837 · Cited by 56
Role of microRNAs in remodeling the tumor microenvironment (Review)
Pan, Z., Tian, Y., Niu, G., & Cao, C. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4952 · Cited by 56
Schultz, K. A. P., Harris, A. K., Messinger, Y. H., Sencer, S., Baldinger, S. R., Dehner, L. P., & Hill, D. A. (2015) · Familial Cancer · doi:10.1007/s10689-015-9831-y · Cited by 55
Jiang, F., He, Y., Wang, H. H., Zhang, H., Zhang, J., Yan, X., Wang, X.-J., Che, Q., Ke, J., Chen, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6350 · Cited by 52
Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex
Garibaldi, F., Falcone, E., Trisciuoglio, D., Colombo, T., Lisek, K., Walerych, D., Sal, G. D., Paci, P., Bossi, G., Piaggio, G., et al. (2016) · Oncogene · doi:10.1038/onc.2016.51 · Cited by 51
The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma
Liu, R., Zhang, H., Wang, X., Zhou, L., Li, H., Deng, T., Qu, Y., Duan, J., Bai, M., Ge, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6257 · Cited by 50
Bose, M., Barman, B., Goswami, A., & Bhattacharyya, S. N. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00464-16 · Cited by 49
Novel insights into PARPs in gene expression: regulation of RNA metabolism
Ke, Y., Zhang, J., Lv, X., Zeng, X., & Ba, X. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03120-6 · Cited by 48
Rabinowits, G., Bowden, M., Flores, L. M., Verselis, S. J., Vergara, V., Jo, V. Y., Chau, N. G., Lorch, J. H., Hammerman, P. S., Thomas, T. M., et al. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00191 · Cited by 47
MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression
Song, Y., Mu, L., Han, X., Li, Q., Dong, B., Li, H., & Liu, X. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1245-9 · Cited by 46
SUMOylation at K707of DGCR8 controls direct function of primary microRNA
Zhu, C., Chen, C., Huang, J. J., Zhang, H., Zhao, X., Deng, R., Dou, J., Jin, H. Z., Chen, R., Xu, M., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv741 · Cited by 45
Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma
Yang, J., Gao, T., Tang, J., Cai, H., Lin, L., & Fu, S. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1677-8 · Cited by 45
Distinguishing mirtrons from canonical miRNAs with data exploration and machine learning methods
Rorbach, G., Unold, O., & Konopka, B. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25578-3 · Cited by 45
Butkytė, S., Čiupas, L., Jakubauskienė, E., Vilys, L., Mocevičius, P., Kanopka, A., & Vilkaitis, G. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0200-y · Cited by 44
Micro-RNA Expression and Function in Lymphomas
Sandhu, S., Croce, C., & Garzon, R. (2011) · Advances in Hematology · doi:10.1155/2011/347137 · Cited by 43
Alteration of miRNA activity via context-specific modifications of Argonaute proteins
Jee, D., & Lai, E. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.008 · Cited by 43
SUMOylation of TARBP2 regulates miRNA/siRNA efficiency
Chen, C., Zhu, C., Huang, J. J., Zhao, X., Deng, R., Zhang, H., Dou, J., Chen, Q., Xu, M., Yuan, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9899 · Cited by 43
B, J. R. V. B., & Griffioen, A. W. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.06.001 · Cited by 42
Cheng, G., Fang, J., Li, G., Liu, H.-H., & Liu, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.17283 · Cited by 41
Zhao, M., Hou, Y., Du, Y.-E., Yang, L., Qin, Y., Peng, M., Liu, S., Wan, X., Qiao, Y., Zeng, H., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.040 · Cited by 41
RISC assembly and post-transcriptional gene regulation in Hepatocellular Carcinoma
Santhekadur, P. K., & Kumar, D. P. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.09.009 · Cited by 39
A mRNA and Cognate MicroRNAs Localize in the Nucleolus
Reyes‐Gutierrez, P., Politz, J. C. R., & Pederson, T. (2014) · Nucleus · doi:10.4161/19491034.2014.990864 · Cited by 37
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer
Casey, M., Prakash, A., Holian, E., McGuire, A., Kalinina, O., Shalaby, A., Curran, C. E., Webber, M., Callagy, G. M., Bourke, E., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5884-x · Cited by 37
Herrera-Carrillo, E., Harwig, A., Liu, Y. P., & Berkhout, B. (2014) · RNA · doi:10.1261/rna.043950.113 · Cited by 33
Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas
Wang, C., Chen, Q., Li, S., Li, S., Zhao, Z., Gao, H., Wang, X., Li, B., Zhang, W., Yuan, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14396 · Cited by 32
Song, X., Zhong, H., Wu, Q., Wang, M., Zhou, J., Zhou, Y., Lu, X., & Ying, B. (2017) · Oncotarget · doi:10.18632/oncotarget.21199 · Cited by 32
MicroRNAs and Tumor Vasculature Normalization: Impact on Anti-Tumor Immune Response
Matejuk, A., Collet, G., Nadim, M., Grillon, C., & Kiéda, C. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0231-4 · Cited by 30
Wang, T., Wang, G., Zhang, X., Wu, D., Wang, G., Wang, G., & Hao, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-12259-w · Cited by 30
Human Argonaute 2 Is Tethered to Ribosomal RNA through MicroRNA Interactions
Atwood, B. L., Woolnough, J. L., Lefevre, G. M., Ribeiro, M. S. J., Felsenfeld, G., & Giles, K. E. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.725051 · Cited by 29
Dissecting the roles of Ephrin-A3 in malignant peripheral nerve sheath tumor by TALENs
Wang, Z., LIU, Z., LIU, B., Liu, G., & Wu, S. (2015) · Oncology Reports · doi:10.3892/or.2015.3966 · Cited by 28
Angiogenesis and Anti-Angiogenesis in Hematological Malignancies
Ribatti, D., Vacca, A., Dammacco, F., & English, D. K. (2003) · Stem Cells and Development · doi:10.1089/152581603321210091 · Cited by 28
Self-citationA novel role for GSK3β as a modulator of Drosha microprocessor activity and MicroRNA biogenesis
Fletcher, C. E., Godfrey, J. D., Shibakawa, A., Bushell, M., & Bevan, C. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw938 · Cited by 28
Santos, E. M. S., Guimarães, T. A., Santos, H. O., Cangussu, L. M. B., de Jesus, S. F., Fraga, C. A. D. C., Cardoso, C. M., Santos, S. H. S., de Paula, A. M. B., Gomez, R. S., et al. (2017) · Tumor Biology · doi:10.1177/1010428317699130 · Cited by 28
Bagheri, F., Tanha, H. M., Naeini, M. M., Ghaedi, K., & Azadeh, M. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5078 · Cited by 27
Xu, S., ZHANG, J., Xue, H., Guo, X., Han, X., Li, T., Guo, X., GAO, X., LIU, Q., & LI, G. (2016) · Neoplasma · doi:10.4149/neo_2017_102 · Cited by 27
Zhang, Y., Wang, B., Chen, X., Li, W., & Dong, P. (2017) · Oncotarget · doi:10.18632/oncotarget.18047 · Cited by 27
Parilla, M., Kadri, S., Patil, S., Fitzpatrick, C. A., Ritterhouse, L. L., Segal, J. P., Collins, J. M., & Pytel, P. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly130 · Cited by 27
Xue, H., Gao, X. C., Xu, S., Zhang, J., Guo, X. H., Yan, S., Li, T., Guo, X., Liu, Q., & LI, G. (2016) · Oncology Reports · doi:10.3892/or.2016.4548 · Cited by 26
Tu, C., Zhong, Y., Nguyen, L., Tsai, A., Sridevi, P., Tarn, W., & Wang, J. Y. J. (2015) · Science Signaling · doi:10.1126/scisignal.aaa4468 · Cited by 25
Santos, P. R. B., Coutinho‐Camillo, C. M., Soares, F. A., Freitas, V. S., Vilas‐Bôas, D. S., Xavier, F. C. D. A., Rocha, C. A. G., Araújo, I., & dos Santos, J. N. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.10.012 · Cited by 23
Enhanced poly ADP-ribosylation in human leukemia lymphocytes and ovarian cancers
Singh, N. K. (1991) · Cancer Letters · doi:10.1016/0304-3835(91)90035-g · Cited by 22
Warner, M. J., Bridge, K. S., Hewitson, J. P., Hodgkinson, M. R., Heyam, A., Massa, B. C., Haslam, J. C., Chatzifrangkeskou, M., Evans, G. J., Plevin, M. J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw631 · Cited by 21
miR‑24 regulates angiogenesis in gliomas
Dai, D., Huang, W., Lu, Q., Chen, H., Liu, J., & Hong, B. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8978 · Cited by 21
Atanasov, G., Dietel, C., Feldbrügge, L., Benzing, C., Krenzien, F., Brandl, A., Katou, S., Schierle, K., Robson, S. C., Splith, K., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25699 · Cited by 19
Changes in NAD/ADP-ribose metabolism in rectal cancer
Yalçıntepe, L., Şener, L. T., Sener, A., Yetkın, G., Tiryaki, D., & Bermek, E. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000300006 · Cited by 18
Analysis of AgoshRNA maturation and loading into Ago2
Harwig, A., Kruize, Z., Yang, Z., Restle, T., & Berkhout, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183269 · Cited by 18
B, J. R. V. B., Nowak-Sliwinska, P. M., van Berkel, M., Wong, T. J., & Griffioen, A. W. (2017) · Angiogenesis · doi:10.1007/s10456-017-9576-3 · Cited by 18
MicroRNA profiles in B-cell non-Hodgkin lymphoma.
Getaneh, Z., Asrie, F., & Melku, M. (2019) · PubMed · Cited by 18
Epigenetic control of tumor angiogenesis
Ribatti, D., & Tamma, R. (2019) · Microcirculation · doi:10.1111/micc.12602 · Cited by 18
Self-citationMiller, S., Jones, L. E., Giovannitti, K., Piper, D., & Serra, M. J. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn525 · Cited by 16
Tumor suppressive effects of the pleiotropically acting miR-195 in colorectal cancer cells
Jahromi, Z. F., Javeri, A., & Taha, M. F. (2019) · EXCLI journal · doi:10.17179/excli2019-1166 · Cited by 16
RNAscope dual ISH–IHC technology to study angiogenesis in diffuse large B-cell lymphomas
Annese, T., Tamma, R., Giorgis, M. D., Ruggieri, S., Maiorano, E., Specchia, G., & Ribatti, D. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01834-z · Cited by 13
Self-citationEvaluating the Oncogenic and Tumor Suppressor Role of XPO5 in Different Tissue Tumor Types
Khan, M. S., Khan, Z. U., Uddin, Y., Mustafa, S. R., Shaukat, I., Pan, J., & Höti, N. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.4.1119 · Cited by 8
Cited by
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381
MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology
Chawra, H. S., Agarwal, M., Mishra, A., Chandel, S. S., Singh, R. P., Dubey, G., Kukreti, N., & Singh, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155091 · Cited by 91
Rusu, I., Pirlog, R., Chiroi, P., Nutu, A., Puia, V. R., Fetti, A. C., Rusu, D. R., Berindan-Neagoe, I., & Al Hajjar, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012370 · Cited by 27
AAV2.7m8-Mediated MicroRNA Expression Suppresses VEGF-Induced Angiogenic Responses in HUVEC
Yang, J. Y., Choi, J.-S., & Park, T. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073123 · Cited by 1
Metadata
- Authors
- Annese, T., Tamma, R., De Giorgis, M., & Ribatti, D.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-27
- Volume
- 10
- Pages
- 581007-581007
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3107931854
- Cited by
- 288
- References
- 279
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.